Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727184 | SCV000617409 | uncertain significance | not provided | 2020-01-16 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22878431, 26153518, 28324197, 28623566) |
Eurofins Ntd Llc |
RCV000727184 | SCV000706462 | uncertain significance | not provided | 2018-03-19 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000670762 | SCV000795658 | uncertain significance | Cholestanol storage disease | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000670762 | SCV003521101 | uncertain significance | Cholestanol storage disease | 2022-03-14 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 513 of the CYP27A1 protein (p.Arg513His). This variant is present in population databases (rs144701596, gnomAD 0.03%). This missense change has been observed in individual(s) with cerebrotendinous xanthomatosis (PMID: 22878431). ClinVar contains an entry for this variant (Variation ID: 449362). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Arg513 amino acid residue in CYP27A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28623566, 31743419, 32714376). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000670762 | SCV004190810 | likely pathogenic | Cholestanol storage disease | 2023-07-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000670762 | SCV001459904 | uncertain significance | Cholestanol storage disease | 2020-09-16 | no assertion criteria provided | clinical testing |